Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Enrolling by invitation Not applicable Interventional Accepts healthy volunteers

Evaluating Pulsed Dye Laser Treatment Parameters on Clearance of Vascular Indications

ClinicalTrials.gov ID: NCT07949747

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT07949747. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 19, 2026, 4:29 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Prospective Clinical Study Evaluating Pulsed Dye Laser Treatment Parameters on Clearance of Vascular Indications

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The goal of this prospective clinical study is to evaluate pulsed dye laser treatment parameters on the clearance of vascular indications, including rosacea and port wine capillary malformations. The main question it aims to answer is: \- Does the use of post-cooling, compared with no post-cooling, affect patient-reported pain scores and treatment outcomes after one treatment session? Participants will: * Receive PDL treatment according to the study protocol. * Complete all required follow-up visits and questionnaires. * Undergo OCT imaging assessments, as applicable to the study protocol.

Study identification

NCT ID
NCT07949747
Recruitment status
Enrolling by invitation
Study type
Interventional
Phase
Not applicable
Enrollment
25 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 6, 2026 (Actual)
Primary completion
Dec 2028 (Estimated)
Completion
Dec 2028 (Estimated)
Last update posted
Nov 19, 2026

2026 – 2028

United States locations

U.S. sites
1
U.S. states
1
U.S. cities
1
Facility City State ZIP Site status
University of California, Irvine Irvine California 92697 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07949747, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 19, 2026 · Synced Nov 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.